Nuclear Coregulatory Complexes in Tregs as Targets to Promote Anticancer Immune Responses

Lanette M Christensen1, Wayne W Hancock1,2

  • 1Department of Pathology and Laboratory Medicine, Children's Hospital of Philadelphia, Philadelphia, PA, United States.

Insights

Regulatory complexes influence T-regulatory (Treg) cell function in cancer. Targeting these epigenetic regulators, including histone deacetylases (HDACs), may offer new cancer immunotherapy strategies.

Area of Science:

  • Immunology
  • Epigenetics
  • Cancer Biology

Background:

  • T-regulatory (Treg) cells exhibit diverse responses in cancer, impacting antitumor immunity.
  • Treg cell function is modulated by multiprotein nuclear complexes controlling gene expression.
  • Epigenetic modifications, particularly involving histone deacetylases (HDACs), are crucial for Treg stability and identity.

Purpose of the Study:

  • To investigate the role of multiprotein nuclear complexes in Treg heterogeneity in cancer.
  • To explore the impact of epigenetic regulators, such as HDACs, on Treg function and cancer response.
  • To assess the therapeutic potential of targeting Treg-associated regulatory complexes in cancer immunotherapy.

Main Methods:

  • Analysis of Treg cell populations in cancer patients.
  • Investigation of epigenetic modifications within Treg cells.
  • Characterization of multiprotein complexes involving HDACs and histone methyltransferases.
  • Assessment of Treg functional impact on antitumor immune responses.

Main Results:

  • Treg cell heterogeneity significantly influences cancer progression and patient outcomes.
  • Epigenetic regulators, including HDACs 1, 2, and 3, are critical for maintaining Foxp3 expression and Treg identity.
  • Specific multiprotein complexes directly impact Treg gene expression and epigenetic profiles.

Conclusions:

  • Multiprotein complexes, particularly those involving HDACs, are key determinants of Treg function in cancer.
  • Targeting these epigenetic regulatory complexes in Tregs presents a promising avenue for developing personalized cancer immunotherapies.

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
652
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
1.7K
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.4K
T Cell Activation and Clonal Selection01:22

T Cell Activation and Clonal Selection

T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
4.2K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.9K